HBV相关慢加急性肝衰竭短期预后模型的建立及评价

王嘉鑫; 程娜; 向天新; 李淑悦; 肖金平; 邬小萍

doi:10.3969/j.issn.1001-5256.2019.06.023

HBV相关慢加急性肝衰竭短期预后模型的建立及评价

DOI: 10.3969/j.issn.1001-5256.2019.06.023

基金项目:

江西省重点研发计划项目(20181BBG78009)；

详细信息

中图分类号: R575.3;R512.62
计量
- 文章访问数: 1195
- HTML全文浏览量: 55
- PDF下载量: 294
- 被引次数: 0
出版历程
- 收稿日期: 2019-01-22
- 出版日期: 2019-06-20

Establishment and evaluation of short-term prognostic model for hepatitis B virus-related acute-on-chronic liver failure

Research funding:

摘要

摘要:
目的建立一个新型的HBV相关慢加急性肝衰竭（HBV-ACLF）短期预后预测模型:MACLF,并评价MACLF评分对HBV-ACLF患者短期预后的预测价值。方法采用回顾性队列研究分析2015年1月-2018年11月南昌大学第一附属医院收治的270例HBV-ACLF患者的临床资料,根据3个月的病情随访情况分为生存组（n=153）和死亡组（n=117）,对影响HBV-ACLF患者短期预后的相关因素进行分析。计数资料2组间比较采用卡方检验,计量资料2组间比较分别采用Mann-Whitney U检验,采用二元logistic回归分析进行多因素分析,多因素分析有意义的指标再次进行二元logistic回归分析并建立模型。绘制受试者工作特征曲线（ROC曲线）评价MACLF评分对HBV-ACLF患者短期预后的预测价值。结果单因素分析结果显示:游离三碘甲状腺原氨酸（FT3）、促甲状腺激素（TSH）、国际标准化比值（INR）、中性粒细胞/淋巴细胞比值（NLR）、PLT、ALT、AST/ALT、TBil、Alb、肌酐（Cr）、总胆固醇（TC）、甘油三酯（TG）、钠（Na）、AFP、血清铁...
- 乙型肝炎病毒 /
- 慢加急性肝功能衰竭 /
- 预后 /
- 危险因素
Abstract:
Objective To establish a new prognostic model, MACLF, for predicting the short-term prognosis of hepatitis B virus-associated acute-on-chronic liver failure (HBV-ACLF) , and to investigate its value in predicting the short-term prognosis of HBV-ACLF.Methods A retrospective cohort study was performed for the clinical data of 270 patients with HBV-ACLF who were admitted to The First Affiliated Hospital of Nanchang University from January 2015 to November 2018. The patients were divided into survival group with 153 patients and death group with 117 patients according to their conditions after 3 months of treatment, and influencing factors for the short-term prognosis of HBV-ACLF were analyzed. The chi-square test was used for comparison of categorical data between two groups, A binary logistic regression analysis was performed for statistically significant indices determined by multivariate analysis and a model was established.and the Mann-Whitney U test was used for comparison of continuous data between two groups. A binary logistic regression analysis was used for multivariate analysis, a binary logistic regression analysis was performed for statistically significant indices determined by multivariate analysis and a model was established, and the receiver operating characteristic (ROC) curve was plotted to evaluate the value of MACLF in predicting the short-term prognosis of HBV-ACLF. Results The univariate analysis showed that there were significant differences between the survival group and the death group in free triiodothyronine (FT3) , thyroid stimulating hormone, international normalized ratio, neutrophil-lymphocyte ratio (NLR) , platelet count (PLT) , alanine aminotransferase, aspartate aminotransferase-alanine aminotransferase ratio, total bilirubin (TBil) , albumin, creatinine, total cholesterol, triglyceride, sodium, alpha-fetoprotein, serum ferritin, Child -Turcotte-Pugh (CTP) class, Model for End-Stage Liver Disease (MELD) score, and complications (hepatic encephalopathy, hepatorenal syndrome, spontaneous peritonitis, gastrointestinal bleeding, and pulmonary infection) (all P < 0. 05) . The multivariate analysis showed that TBil (odds ratio [OR]= 1. 007, P = 0. 001) , INR (OR = 5. 750, P < 0. 001) , FT3 (OR = 0. 084, P = 0. 003) , PLT (OR =0. 987, P = 0. 022) , hepatorenal syndrome (OR = 7. 146, P = 0. 045) , and pulmonary infection (OR = 3. 816, P = 0. 023) were independent influencing factors for the short-term prognosis of HBV-ACLF. Therefore, a new model of MACLF was established for the short-term prognosis of HBV-ACLF: Logit (P) = 0. 007 ×[TBil (umol/L) ]+ 2. 181 × INR-2. 762 × [FT3 (pg/mL) ]-0. 014 ×[PLT (×109/L) ]+ 1. 797 × [hepatorenal syndrome (with: 1; no: 0) ]+ 1. 339 × [pulmonary infection (with: 1; no: 0) ]-2. 291. The ROC curve analysis showed that MACLF had significantly higher area under the ROC curve (0. 934) and Youden index (0. 774) than CTP class, MELD, and MELD combined with serum sodium concentration. Conclusion The new model of MACLF has a good value in predicting the short-term prognosis of patients with HBV-ACLF after 3 months of treatment.
- hepatitis B virus /
- acute-on-chronic liver failure /
- prognosis /
- risk factors

HTML全文

参考文献(18)

[1] LI LJ, DUAN ZP.Diagnostic and treatment guidelines for liver failure (2012 version) [J].Chin J Clin Infect Dis, 2012, 5 (6) :321-327. (in Chinese) 李兰娟, 段钟平.肝衰竭诊治指南 (2012年版) [J].中华临床感染病杂志, 2012, 5 (6) :321-327.

[2]SARIN SK, KEDARISETTY CK, ABBAS Z, et al.Acute-onchronic liver failure:Consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014[J].Hepatol Int, 2014, 8 (4) :453-471.

[3]WLODZIMIROW KA, ESLAMI S, ABU-HANNA A, et al.Asystematic review on prognositc indicators of acute on chronic liver failure and their predictive value for mortality[J].Liver Int, 2013, 33 (1) :40-52.

[4]CHENG XP, ZHAO J, CHEN Y, et al.Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict shot-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis[J].Eur JGastroenterol Hepatol, 2016, 28 (4) :444-448.

[5]MOREAU R, JALAN R, GINES P, et al.Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J].Gastroenterology, 2013, 144 (7) :1426-1437.

[6]DING R, ZHAO H, WANG Q, et al.Prognostic value of low triiodothyronine syndrome on short-term prognosis of patients with acute-on-chronic liver failure[J/CD].Chin J Liver Dis:Electronic Edition, 2018, 10 (4) :90-95. (in Chinese) 丁蕊, 赵红, 王琦, 等.低三碘甲腺原氨酸综合征对慢加急性肝衰竭患者短期预后的预测价值[J/CD].中国肝脏病杂志:电子版, 2018, 10 (4) :90-95.

[7]MALINCHOC M, KAMATH PS, GORDON FD, et al.A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J].Hepatology, 2000, 31 (4) :864-871.

[8]KAMATH PS, WIESNER RH, MALINCHOC M, et al.A model to predict survival in patients with end-stage liver disease[J].Hepatology, 2001, 33 (2) :464-470.

[9]WIESNER R, EDWARDS E, FREEMAN R, et al.Model for end-stage liver disease (MELD) and allocation of donor livers[J].Gastroenterology, 2003, 124 (1) :91-96.

[10]ZHANG H, JIA L, YAO SW, et al.Value of MELD combined with serum sodium concentration in predicting the short-term outcome of patients with HBV-related acute-on-chronic liver failure in China:A meta-analysis[J].J Clin Hepatol, 2018, 34 (9) :1950-1955. (in Chinese) 张辉, 贾雷, 姚士伟, 等.MELD-Na评分对我国HBV相关慢加急性肝衰竭短期预后预测价值的Meta分析[J].临床肝胆病杂志, 2018, 34 (9) :1950-1955.

[11]BIGGINS SW, KIM WR, TERRAULT NA, et al.Evidencebased incorporation of serum sodium concentration into MELD[J].Gastroenterology, 2006, 130 (6) :1652-1660.

[12]DUSEIA A, CHOUDHARV NS, GUPTA S, et al.APACHEⅡscore is superior to SOFA, CTP and MELD in predicting the short-term mortality in patients with acute-on-chronic liver failure (ACLF) [J].J Dig Dis, 2013, 14 (9) :484-490.

[13]AQRAWAL S, DUSEIA A, GUPTA T, et al.Simple organ failure count versus CANONIC grading system for predicting mortality in acute-on-chronic liver failure[J].J Gastroenterol Hepatol, 2015, 30 (3) :575-581.

[14]KEDARISETTY CK, ANAND L, BHARDW-AJ A, et al.Combinaton of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis[J].Gastroenterology, 2015, 148 (7) :1362-1370.

[15]ROUILLARD SS, BASS NM, ROBERTS JP, et al.Severe hyperbilirubinemia after creation of transjugular intrahepatic portosystemic shunts:Natural history and predictors of outcome[J].Ann Int Med, 1998, 128 (5) :374-377.

[16]CONN HO.A peek at the Child-Turcotte classification[J].Hepatology, 1981, 1:673-676.

[17]YANG MY, LI B, DING HG.The effects of liver disease on endocrine hormone[J].Chin J Hepatol, 2014, 22 (3) :168-170. (in Chinese) 杨梦媛, 李冰, 丁惠国.肝脏疾病对内分泌激素的影响[J].中华肝脏病杂志, 2014, 22 (3) :168-170.

[18]LI WY, ZHANG MX, QI TT, et al.The potential factors contributing to thrombocytopenia in acute on chronic liver failure patients[J].Chin Hepatol, 2015, 20 (6) :457-461. (in Chinese) 李文燕, 张明霞, 祁婷婷, 等.慢加急性肝衰竭患者血小板减少的可能原因[J].肝脏, 2015, 20 (6) :457-461.

施引文献

资源附件(0)

访问统计